2022
DOI: 10.3390/cells11020254
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways

Abstract: In this study, we identified a novel pyrazole-based derivative (P3C) that displayed potent cytotoxicity against 27 human cancer cell lines derived from different tissue origins with 50% cytotoxic concentrations (CC50) in the low micromolar and nanomolar range, particularly in two triple-negative breast cancer (TNBC) cell lines (from 0.25 to 0.49 µM). In vitro assays revealed that P3C induces reactive oxygen species (ROS) accumulation leading to mitochondrial depolarization and caspase-3/7 and -8 activation, su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 86 publications
0
5
0
Order By: Relevance
“…Cell suspensions were immediately examined by flow cytometry and 100,000 events were acquired for a well‐defined cell cycle distribution profile. Data was analyzed via the Kaluza 1.3 Flow Cytometry Software [31,32] …”
Section: Methodsmentioning
confidence: 99%
“…Cell suspensions were immediately examined by flow cytometry and 100,000 events were acquired for a well‐defined cell cycle distribution profile. Data was analyzed via the Kaluza 1.3 Flow Cytometry Software [31,32] …”
Section: Methodsmentioning
confidence: 99%
“…needed to kill 50% of the cell population at a given time point. From the percentage of cell death for each technical replicate at a concentration above and below 50% cell death, CC 50 for each cell line was calculated via linear interpolation and averaged to obtain the reported values [ 7 , 30 , 31 ].…”
Section: Methodsmentioning
confidence: 99%
“…In these experiments, 5 × 10 6 HL-60 cell samples were collected in microcentrifuge tubes and treated with a sub-CC 50 dose, 0.01 μM or 0.1 μM, of Tpz-1 and incubated for 3 h at 37 °C. The cells in each sample were lysed, their protein concentrations determined, and Multiplex Luminex assays were performed following the same procedure as the experimental compound P3C [ 7 ]. Acquisition and data analysis were performed using Luminex xPONENT 3.1 software.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…As director of our Cellular Characterization Core and Biorepository facility of the Border Biomedical Research Center, which is funded by Research Centers at Minority Institutions, I was able to build a “state-of-the-art” drug-screening facility to continue searching for anticancer agents. Using this facility, we discovered several novel compounds with potent activity against a variety of cancer cell lines ( Santiago-Vazquez et al , 2014 ; Gutierrez et al , 2019, 2022 ). Our group also determined that a known antimalarial drug has potent anticancer activity and is a topoisomerase II inhibitor ( Villanueva et al ., 2018, 2021 ).…”
Section: Henrietta Lacks’ (Hela) Cells and My Scientific Renaissancementioning
confidence: 99%